NCT05386446View on ClinicalTrials.gov

Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

June 10, 2020

Study Completion Date

June 15, 2020

Conditions
COVID-19 Respiratory Infection
Interventions
DRUG

Interferon gamma human recombinant (IFN-G)

nasal form

Trial Locations (1)

121374

City Clinical Hospital named after M.E. Zhadkevich Moscow City Health Department, Moscow

All Listed Sponsors
lead

SPP Pharmaclon Ltd.

INDUSTRY

NCT05386446 - Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19 | Biotech Hunter | Biotech Hunter